IL6 and Stroke: Yet, few retrospective clinical studies have provided evidence that pro‐inflammatory mediators such as IL‐6 and IL‐1β remained elevated in circulation even 3 months after stroke onset (Liesz et al, 2013; Stanne et al, 2022).